Morphine Sulfate — Class II drug recall D-1007-2020
Terminated recall by Redline Pharmacy Solutions, reported 2020-03-18, distributed in NE. Lack Of Processing Controls
| Recall number | D-1007-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Redline Pharmacy Solutions, Hastings, NE, United States |
| Recall initiated | 2020-02-24 |
| Classified | 2020-03-12 |
| Reported by FDA | 2020-03-18 |
| Terminated | 2022-03-31 |
| Distributed | NE |
| Quantity | 1 |
Product
Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Reason for recall
Lack Of Processing Controls
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1007-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.